1615 related items for PubMed ID: 15598475
1. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study.
Busse W, Levine B, Andriano K, Lavecchia C, Yegen U.
Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475
[Abstract] [Full Text] [Related]
2. Efficacy and safety of formoterol delivered via a new multidose dry powder inhaler (Certihaler) in adolescents and adults with persistent asthma.
LaForce C, Prenner BM, Andriano K, Lavecchia C, Yegen U.
J Asthma; 2005 Mar; 42(2):101-6. PubMed ID: 15871441
[Abstract] [Full Text] [Related]
3. Double-blind, double-dummy, multinational, multicenter, parallel-group design clinical trial of clinical non-inferiority of formoterol 12 microg/unit dose in a b.i.d. regimen administered via an HFA-propellant-pMDI or a dry powder inhaler in a 12-week treatment period of moderate to severe stable persistent asthma in adult patients.
Dusser D, Vicaut E, Lefrançois G, Formoterol HFA group.
Respiration; 2005 Mar; 72 Suppl 1():20-7. PubMed ID: 15915009
[Abstract] [Full Text] [Related]
4. The effect of budesonide and formoterol in one pressurized metered-dose inhaler on patient-reported outcomes in adults with mild-to-moderate persistent asthma.
Murphy K, Nelson H, Parasuraman B, Boggs R, Miller C, O'Dowd L.
Curr Med Res Opin; 2008 Mar; 24(3):879-94. PubMed ID: 18267051
[Abstract] [Full Text] [Related]
5. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
FitzGerald JM, Boulet LP, Follows RM.
Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
[Abstract] [Full Text] [Related]
6. Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial.
Baumgartner RA, Hanania NA, Calhoun WJ, Sahn SA, Sciarappa K, Hanrahan JP.
Clin Ther; 2007 Feb; 29(2):261-78. PubMed ID: 17472819
[Abstract] [Full Text] [Related]
7. Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma.
Corren J, Korenblat PE, Miller CJ, O'Brien CD, Mezzanotte WS.
Clin Ther; 2007 May; 29(5):823-843. PubMed ID: 17697902
[Abstract] [Full Text] [Related]
8. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial.
Noonan M, Rosenwasser LJ, Martin P, O'Brien CD, O'Dowd L.
Drugs; 2006 May; 66(17):2235-54. PubMed ID: 17137405
[Abstract] [Full Text] [Related]
9. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
Murphy K, Noonan M, Silkoff PE, Uryniak T.
Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
[Abstract] [Full Text] [Related]
10. Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids.
Hampel FC, Martin P, Mezzanotte WS.
J Asthma; 2008 May; 45(4):265-72. PubMed ID: 18446589
[Abstract] [Full Text] [Related]
11. Comparable efficacy and tolerability of formoterol (Foradil) administered via a novel multi-dose dry powder inhaler (Certihaler) or the Aerolizer dry powder inhaler in patients with persistent asthma.
Dahl R, Creemers JP, Van Noord J, Sips A, Della Cioppa G, Thomson M, Andriano K, Kottakis J, Fashola T.
Respiration; 2004 May; 71(2):126-33. PubMed ID: 15031566
[Abstract] [Full Text] [Related]
12. Formoterol delivered via the dry powder Aerolizer inhaler versus albuterol MDI and placebo in mild-to-moderate asthma: a randomized, double-blind, double-dummy trial.
Pleskow W, LaForce CF, Yegen U, Matos D, Della Cioppa G.
J Asthma; 2003 May; 40(5):505-14. PubMed ID: 14529100
[Abstract] [Full Text] [Related]
13. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA, Rooklin A, Schoaf L, Scott C, Ellsworth A, House K, Dorinsky P.
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[Abstract] [Full Text] [Related]
14. Patient-reported outcomes in adults with moderate to severe asthma after use of budesonide and formoterol administered via 1 pressurized metered-dose inhaler.
Chervinsky P, Baker J, Bensch G, Parasuraman B, Boggs R, Martin P, O'Dowd L.
Ann Allergy Asthma Immunol; 2008 Nov; 101(5):463-73. PubMed ID: 19055199
[Abstract] [Full Text] [Related]
15. A randomized, 12-week, double-blind, placebo-controlled study comparing formoterol dry powder inhaler with albuterol metered-dose inhaler.
Bensch G, Lapidus RJ, Levine BE, Lumry W, Yegen U, Kiselev P, Della Cioppa G.
Ann Allergy Asthma Immunol; 2001 Jan; 86(1):19-27. PubMed ID: 11206232
[Abstract] [Full Text] [Related]
16. A randomized, double-blind, double-dummy, single-dose, efficacy crossover trial comparing formoterol-HFA (pMDI) versus formoterol-DPI (Aerolizer) and placebo (pMDI or Aerolizer) in asthmatic patients.
Bousquet J, Huchon G, Leclerc V, Vicaut E, Lefrançois G.
Respiration; 2005 Jan; 72 Suppl 1():6-12. PubMed ID: 15915007
[Abstract] [Full Text] [Related]
17. A randomized, double-blind, double-dummy, safety crossover trial comparing cumulative doses up to 96 microg of formoterol delivered via an HFA-134a-propelled pMDI vs. same cumulative doses of formoterol DPI and placebo in asthmatic patients.
Molimard M, Guenolé E, Duvauchelle T, Vicaut E, Lefrançois G.
Respiration; 2005 Jan; 72 Suppl 1():28-34. PubMed ID: 15915010
[Abstract] [Full Text] [Related]
18. Clinically equivalent bronchodilatation achieved with formoterol delivered via Easyhaler and Aerolizer.
Dubakiene R, Nargela R, Sakalauskas R, Vahteristo M, Silvasti M, Lähelmä S.
Respiration; 2006 Jan; 73(4):441-8. PubMed ID: 16432294
[Abstract] [Full Text] [Related]
19. Lung function and asthma control with beclomethasone and formoterol in a single inhaler.
Huchon G, Magnussen H, Chuchalin A, Dymek L, Gonod FB, Bousquet J.
Respir Med; 2009 Jan; 103(1):41-9. PubMed ID: 18977646
[Abstract] [Full Text] [Related]
20. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
Berger WE, Noonan MJ.
J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
